ARQ-252 cream 0.3%
ARQ-252-205
Phase 2 small_molecule completed
Quick answer
ARQ-252 cream 0.3% for Chronic Hand Eczema is a Phase 2 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Chronic Hand Eczema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed